Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …
based approaches aimed to tackle pulmonary ailments in recent years. The current …
Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future
Tuberculosis (TB) is a contagious and airborne infectious disease caused by the pathogen
Mycobacterium tuberculosis (Mtb). In spite of substantial research efforts, continuous …
Mycobacterium tuberculosis (Mtb). In spite of substantial research efforts, continuous …
Inhalable solid lipid nanoparticles for intracellular tuberculosis infection therapy: macrophage-targeting and pH-sensitive properties
Mycobacterium tuberculosis (MTB) is one of the most threatening pathogens for its latent
infection in macrophages. The intracellular MTB isolated itself from drugs and could spread …
infection in macrophages. The intracellular MTB isolated itself from drugs and could spread …
An inhalable theranostic system for local tuberculosis treatment containing an isoniazid loaded metal organic framework Fe-MIL-101-NH2—from raw MOF to drug …
G Wyszogrodzka-Gaweł, P Dorożyński, S Giovagnoli… - Pharmaceutics, 2019 - mdpi.com
The theranostic approach to local tuberculosis treatment allows drug delivery and imaging of
the lungs for a better control and personalization of antibiotic therapy. Metal-organic …
the lungs for a better control and personalization of antibiotic therapy. Metal-organic …
Dry powder inhalable formulations for anti-tubercular therapy
Tuberculosis (TB) is an intracellular infectious disease caused by the airborne bacterium,
Mycobacterium tuberculosis. Despite considerable research efforts, the treatment of TB …
Mycobacterium tuberculosis. Despite considerable research efforts, the treatment of TB …
Microencapsulated solid lipid nanoparticles as a hybrid platform for pulmonary antibiotic delivery
DP Gaspar, MM Gaspar, CV Eleuterio… - Molecular …, 2017 - ACS Publications
Solid lipid nanoparticles (SLN) containing rifabutin (RFB), with pulmonary administration
purposes, were developed through a technique that avoids the use of organic solvents or …
purposes, were developed through a technique that avoids the use of organic solvents or …
A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics
Treatment for tuberculosis (TB) using the standard oral antibiotic regimen is effective but
inefficient, requiring high drug dosing and lengthy treatment times. Three concurrent first-line …
inefficient, requiring high drug dosing and lengthy treatment times. Three concurrent first-line …
Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery
MS Miranda, MT Rodrigues, RMA Domingues… - Materials Science and …, 2018 - Elsevier
The growing interest on polymeric delivery systems for pulmonary administration of drugs
anticipates a more direct and efficient treatment of diseases such as tuberculosis (TB) that …
anticipates a more direct and efficient treatment of diseases such as tuberculosis (TB) that …
Dry powder antibiotic aerosol product development: inhaled therapy for tuberculosis
Inhaled therapies offer a unique approach to the treatment of tuberculosis (TB) using a
relevant target organ system as a route of administration. The number of research reports on …
relevant target organ system as a route of administration. The number of research reports on …
Cationic inhalable particles for enhanced drug delivery to M. tuberculosis infected macrophages
Inhalable microparticle-based drug delivery platforms are being investigated extensively for
Tuberculosis (TB) treatment as they offer efficient deposition in lungs and improved …
Tuberculosis (TB) treatment as they offer efficient deposition in lungs and improved …